Silvaco Group Inc. Enters Strategic R&D Partnership with Fraunhofer ISIT to Advance GaN Device Technology

Reuters
24 Jun
<a href="https://laohu8.com/S/SVCO">Silvaco Group</a> Inc. Enters Strategic R&D Partnership with Fraunhofer ISIT to Advance GaN Device Technology

Silvaco Group Inc., a leader in semiconductor design and digital twin modeling, has announced a strategic R&D collaboration with the Fraunhofer Institute for Silicon Technology (ISIT). This partnership aims to accelerate the development of next-generation Gallium Nitride (GaN) devices by leveraging Silvaco's Power Devices Solution to perform Design Technology Co-Optimization (DTCO). This collaboration is aligned with the EU Chips Act initiative and Fraunhofer ISIT's efforts in the APECS pilot line. The partnership will not only enhance the development of high voltage GaN devices but also advance Silvaco's TCAD tools. Additionally, Fraunhofer ISIT plans to utilize Silvaco's Victory TCAD™ platform to train future semiconductor device engineers, ensuring continued innovation in the field.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silvaco Group Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9483243-en) on June 24, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10